A case of myasthenia gravis in which the interval to repeated exacerbation was prolonged by L-carnitine

We report the case of a 62-year-old woman diagnosed with myasthenia gravis. She felt dyspnea and weakness of bilateral upper limbs, followed by left blepharoptosis. Pyridostigmine markedly improved her symptoms. But later, blepharoptosis and head drop worsened and predonisolone was ineffective. Yet, after intravenous immunoglobulin therapy her symptoms markedly improved. However, her head drop worsened at intervals of 25.79 days on average. She was administered L-carnitine, and the interval until exacerbation became longer (40.67 days on average). This case is interesting because L-carnitine therapy has never been reported as therapy for myasthenia gravis. doi：10.11482/KMJ-E43（1）1 (Accepted on December 24, 2016)

Author

Yamada H, et al

Volume

43

Issue

1

Pages

1-4

Published

2017.2.15

Kawasaki Medical Society has been contributing to the advancement of medical science by encouraging medical research and enhancing knowledge and skills of all faculty, interns, residents, and PhD candidates at Kawasaki Medical School and Hospital since 1975.
We will introduce research papers published in the Kawasaki Medical Journal and Kawasaki Medical Journal of Liberal Arts and Sciences on this website aiming at continuous achievement of our original purpose, and contributing to the development and success of medical researches.